Several pharmaceutical companies showcased data on their BTK inhibitors at the ASCO 2023 conference, including Ono ...

Acalabrutinib plus obinutuzumab shows superior long-term outcomes in treatment-naive chronic lymphocytic leukemia.

2025 BofA China Trailblazers Biotech Conference: One-on-one investor meetings on October 20-21 ...

Recent court filings show Hulk Hogan's family is considering filing a medical malpractice lawsuit in connection with his death. What to know ...

Hogan's widow, Sky Daily, and son, Nick Bollea, filed a petition in Pinellas County, FL, to extend the statute of limitations ...

Medical examiner's records show that Hulk Hogan died from a heart attack, but there have been ongoing questions from his ...

Hogan’s wife and son reportedly filed a petition to extend the statute of limitations by 90 days for an investigation into ...

The FDA has granted fast track designation to UB-VV111 for the treatment of relapsed/refractory large B-cell lymphoma (LBCL) following 2 or more prior lines of therapy and relapsed/refractory chronic ...

Pirtobrutinib is currently approved for the treatment of patients with CLL/SLL who have received at least 2 prior lines of therapy.

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Members of the NYPD’s Crime Scene Unit examine a ...

CM04S1, a multi-antigen COVID-19 vaccine for immunocompromised individuals: clinical evaluation to date. For more information on the conference, please visit International Workshop on Chronic ...